What is the treatment for urosepsis caused by yeast?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urosepsis Caused by Yeast

For urosepsis caused by yeast, fluconazole 400 mg (6 mg/kg) daily is the recommended first-line treatment for patients with fluconazole-susceptible Candida species. 1

Initial Assessment and Diagnosis

  • Obtain urine and blood cultures before initiating antifungal therapy
  • Evaluate for urinary tract obstruction with imaging (ultrasound, CT)
  • Assess for disseminated infection with dilated retinal examination within first week of therapy 1

Treatment Algorithm

First-line Treatment:

  • Fluconazole-susceptible Candida species:
    • Fluconazole 400 mg (6 mg/kg) daily for at least 2 weeks 1, 2
    • Continue treatment until all signs and symptoms have resolved

Alternative Treatments:

  • For fluconazole-resistant C. glabrata:

    • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR
    • Oral flucytosine 25 mg/kg 4 times daily 1
  • For severely ill patients or those with suspected disseminated infection:

    • Liposomal Amphotericin B 3-5 mg/kg daily with or without flucytosine 1
    • Consider step-down to fluconazole after clinical improvement

Source Control

  • Eliminate predisposing factors (indwelling bladder catheters) whenever feasible 1
  • For urinary tract obstruction, urgent decompression is required:
    • Nephrostomy tube placement or stent insertion
    • Removal of stones if present

Special Populations

Neutropenic Patients:

  • Treat as for candidemia with an echinocandin (caspofungin 70-mg loading dose, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200-mg loading dose, then 100 mg daily) 1
  • Duration: at least 2 weeks after first negative blood culture and resolution of neutropenia 1

Patients Undergoing Urologic Procedures:

  • Oral fluconazole 400 mg (6 mg/kg) daily OR
  • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1

Duration of Therapy

  • For uncomplicated candiduria with sepsis: minimum 2 weeks of therapy 1
  • For pyelonephritis with sepsis: 2-4 weeks of therapy 1
  • For disseminated candidiasis: continue until all signs, symptoms, and radiological abnormalities have resolved (typically 4-6 weeks) 1

Monitoring

  • Daily assessment of vital signs and clinical status
  • Follow-up urine cultures to document clearance
  • Monitor renal function if using amphotericin B
  • For persistent candiduria, evaluate for structural abnormalities or foreign bodies

Important Caveats

  • Asymptomatic candiduria generally does not require treatment unless the patient is at high risk for dissemination (neutropenia, very low birth weight infants) 1
  • Fluconazole achieves high urinary concentrations and is preferred over newer azoles and echinocandins, which do not achieve adequate urine concentrations 3
  • Removal of urinary catheters alone may clear candiduria in up to 50% of cases 3
  • For urinary fungus balls, surgical removal is strongly recommended with antifungal therapy 1

Urosepsis caused by yeast represents approximately 25% of all sepsis cases 4, 5 and requires prompt treatment to prevent complications. Early diagnosis, appropriate antifungal therapy, and control of any complicating factors in the urinary tract are essential for successful management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Research

Diagnosis and management for urosepsis.

International journal of urology : official journal of the Japanese Urological Association, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.